HIGHLIGHTS
- who: Iridium(u2162) complexes and collaborators from the Institute of Anticancer Agents Development and Theranostic Application, School of Chemistry and Chemical Engineering, Qufu Normal University, Qufu, China, College of Life Sciences, Qufu Normal University, Qufu, China have published the research: Lysosomal Targeted Cyclometallic Iridium( u2162 ) Salicylaldehyde-Coumarin Schiff Base Complexes and Anticancer Application, in the Journal: (JOURNAL)
- what: The authors demonstrate that Ir2 can target lysosomes and trigger lysosome-mediated apoptosis in A549 cell line.
- how: In this study flow cytometry was utilized to analyze this change after the treatment of Ir2 at . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.